Building on its 2004 study of the Burden of Skin Disease, the Society for Investigative Dermatology (SID) has launched a new initiative to determine the Burden of Skin Disease Co-Morbidities. In recent years, there has been increasing evidence linking various skin diseases with a number of co-morbid conditions, some of which occur as a consequence of treatment for severe skin disease.
Overall Co-Morbidities Project Purpose
The multi-year, multi component project is designed to facilitate interaction and collaboration across multiple medical disciplines and fields, in order to
- identify the depth and state of knowledge on connections between dermatologic and non-dermatologic diseases, including their existence, scientific basis and prevalence;
- make recommendations pertaining to support of basic and clinical research in the area; and
- enhance public (including media and policy) awareness and public and policy support for basic and clinical research in the area.
- Centocor, Inc.
- OSI Pharmaceuticals